checkAd

Recce Pharmaceuticals Announces The Pew Charitable Trusts' Addition of Recce’s Lead Compound RECCE 3 | Diskussion im Forum

eröffnet am 16.03.21 19:26:18 von
neuester Beitrag 18.03.21 11:23:18 von


Beitrag schreiben

Begriffe und/oder Benutzer

 

Fragen

 Ja Nein
Avatar
16.03.21 19:26:18
Es handelt sich um einen automatisiert angelegten Thread zur Nachricht "Recce Pharmaceuticals Announces The Pew Charitable Trusts' Addition of Recce’s Lead Compound RECCE 327 to List of Antibiotic Treatments in Clinical Development" vom Autor globenewswire

Highlights: RECCE 327 included in The Pew Charitable Trusts’ annual assessment of non-traditional antibiotic treatment in clinical developmentRECCE 327 is the only synthetic polymer drug candidate for treating sepsis currently in developmentNew …

Lesen Sie den ganzen Artikel: Recce Pharmaceuticals Announces The Pew Charitable Trusts' Addition of Recce’s Lead Compound RECCE 327 to List of Antibiotic Treatments in Clinical Development
Avatar
16.03.21 19:26:18
major news - the ONLY synthetic antibiotic in development (a category for such) AND the ONLY sepsis drug candidate!
Recce Pharmaceuticals | 0,645 €
Avatar
18.03.21 11:23:18
Recce Pharmaceuticals | 0,675 €


Beitrag zu dieser Diskussion schreiben

Recce Pharmaceuticals Announces The Pew Charitable Trusts' Addition of Recce’s Lead Compound RECCE 3